Cargando…

Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy

Hepatocellular carcinoma (HCC) is highly heterogeneous. Molecular subtyping for guiding immunotherapy is warranted. Previous studies have indicated that enhancer RNAs (eRNAs) are involved in tumor heterogeneity and immune infiltration. However, the eRNA landscape and its correlation with immune infi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bu, Xiaoyun, Liu, Shuang, Wen, Dongsheng, Kan, Anna, Xu, Yujie, Lin, Xuanjia, Shi, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310078/ https://www.ncbi.nlm.nih.gov/pubmed/35919459 http://dx.doi.org/10.1016/j.omto.2022.07.001

Ejemplares similares

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
por: Zhu, Jun, et al.
Publicado: (2022)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy
por: Haworth, Kellie B., et al.
Publicado: (2017)

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
por: Li, Bo, et al.
Publicado: (2016)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
por: Liu, Jingkai, et al.
Publicado: (2021)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
por: Feng, Peng, et al.
Publicado: (2022)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma
por: Lai, Zhicheng, et al.
Publicado: (2022)

Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy
por: Sun, Jing, et al.
Publicado: (2021)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
por: Zhao, Liang, et al.
Publicado: (2021)

Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models
por: Li, Huikai, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications
por: Zhao, Weihong, et al.
Publicado: (2014)

Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
por: Li, Chenlu, et al.
Publicado: (2021)

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
por: Li, Lingling, et al.
Publicado: (2023)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma
por: Yang, Xuejie, et al.
Publicado: (2023)

Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications
por: Huang, Xiaowen, et al.
Publicado: (2020)

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

Tissue-Resident Lymphocytes: Implications in Immunotherapy for Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2020)

Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma
por: Wei, Baojun, et al.
Publicado: (2021)

In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma
por: Guo, Li, et al.
Publicado: (2022)

Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes
por: Wang, Xiaoqin, et al.
Publicado: (2022)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
por: Giraud, Julie, et al.
Publicado: (2021)

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance
por: Ren, Runhan, et al.
Publicado: (2017)

Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy
por: Li, Wei Tse, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uv6o71q6c7hbsu6qldni1tc2ir